MetLife Investment Management LLC Increases Holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
MetLife Investment Management LLC increased its stake in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 65.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 117,732 shares of the biopharmaceutical company’s stock after buying an additional 46,682 shares during the period. MetLife Investment Management LLC’s holdings in Esperion Therapeutics were worth $259,000 […]
MetLife Investment Management LLC increased its stake in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 65.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 117,732 shares of the biopharmaceutical company’s stock after buying an additional 46,682 shares during the period. MetLife Investment Management LLC’s holdings in Esperion Therapeutics were worth $259,000 […]
